France Tightens Rules in Wake of Fatal Clinical Trial

May 25, 2016

(Science) – The French government is taking measures to lower the health risks to volunteers in clinical trials in the wake of the final report about a study that killed one person and landed five others in the hospital in January. Furthermore, the contract research company that conducted the study, Rennes, France–based Biotrial, must within a month provide a “plan of action” explaining how it will avoid a repeat of its mistakes during the trial or lose its operating license, French health minister Marisol Touraine said today at a press conference on the report’s release.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.